You are currently viewing Ottavio Alfieri’s unique insights on the Clover technique

Ottavio Alfieri’s unique insights on the Clover technique

  • Post published:

The Clover technique in tricuspid valve treatment is directly explained by its inventor: in his video, Professor Ottavio Alfieri tells us the surgical Clover’s story from his first patient 25 years ago, to the catheter-based future he sees for it. 

It all began with a patient who had torrential tricuspid regurgitation (TR) after a car accident. Professor Alfieri’s idea was to join the central part of the free edge of three valve leaflets with a single stitch, creating a triple-orifice valve – the surgical Clover configuration. “The result was really spectacular,” he recalls. 

The surgical technique was then used mainly in more complex cases: patients with leaflet tethering, prolapse, or a combination of the two. 

His team confirmed these results in a long-term study published in the European Journal of Cardio-Thoracic Surgery, conducted in around 100 patients with complex TR, treated with the Clover technique and followed for nearly up to 15 years. In 80% of those patients, regurgitation was on average mild or less at nine-year follow-up. 

Groups around the world have since adopted the clover technique, including StarTric clinical advisor Antonios Pitsis in Greece, who performs it endoscopically and found no significant difference between patients treated with or without an associated annuloplasty. 

Professor Alfieri explains why: “The Clover technique can, in a way, act as an indirect annuloplasty, preventing the annulus from dilatation. The degree of annuloplasty is dictated by the distance of the stitch from the free edge of the leaflets.” 

 He believes the Clover technique can be reproduced in a minimally invasive way via a catheter, just as the clip reproduced the edge-to-edge repair he pioneered as the Alfieri Stitch for the mitral valve. And if it can, as he puts it, “it is nice to know that the addition of the annuloplasty is not absolutely essential.” 

Bringing the clover from surgical technique to a transcatheter approach is the work we are pursuing with TriClover, the StarTric next-generation T-TEER device currently in preclinical development. Our objective is making tricuspid valve repair a viable treatment option for a wider range of patients with TR. 

Watch the full interview, part of our video series The Tricuspid Valve, to hear the story from the surgeon who started it.